• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞核表皮生长因子受体(EGFR)是顺铂耐药性和DNA修复所必需的。

Nuclear EGFR is required for cisplatin resistance and DNA repair.

作者信息

Hsu Sheng-Chieh, Miller Stephanie A, Wang Yan, Hung Mien-Chie

出版信息

Am J Transl Res. 2009 Mar 8;1(3):249-58.

PMID:19956435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2776325/
Abstract

The epidermal growth factor receptor (EGFR) has been shown to be able to translocate to the nucleus where it is involved in many cellular process including transcriptional regulation and DNA repair. Recently, it has been shown that the DNA damage-inducing agents ionizing radiation (IR) and cisplatin are able to induce EGFR nuclear localization, and this nuclear localization is correlated with increased DNA-PK activity, which plays an essential role in DNA double stranded repair. Here we sought to determine if there is a causal relationship between nuclear EGFR and DNA repair activity. We found that mutation in the nuclear localization signal (NLS) of EGFR (mNLS), known to be unable to translocate to the nucleus, released EGFR induced resistance to cisplatin. Re-introduction of an NLS in the C-terminal allowed EGFR to re-enter the nucleus and the cells regained resistance to cisplatin. In addition, we show that the re-expression of a functional nuclear localization sequence in EGFR (mNLS-R) is not only able to restore its resistance to cisplatin, but also reduced the DNA damage caused by cisplatin, and restored DNA repair activity. Thus, we demonstrate here that nuclear EGFR is required for DNA repair and resistance to cisplatin treatment.

摘要

表皮生长因子受体(EGFR)已被证明能够转运至细胞核,在包括转录调控和DNA修复在内的许多细胞过程中发挥作用。最近的研究表明,DNA损伤诱导剂电离辐射(IR)和顺铂能够诱导EGFR的核定位,而这种核定位与DNA-PK活性的增加相关,DNA-PK在DNA双链修复中起着至关重要的作用。在此,我们试图确定核EGFR与DNA修复活性之间是否存在因果关系。我们发现,已知无法转运至细胞核的EGFR核定位信号(NLS)突变(mNLS)可消除EGFR诱导的对顺铂的抗性。在C末端重新引入NLS可使EGFR重新进入细胞核,细胞也恢复了对顺铂的抗性。此外,我们还表明,在EGFR中重新表达功能性核定位序列(mNLS-R)不仅能够恢复其对顺铂的抗性,还能减少顺铂引起的DNA损伤,并恢复DNA修复活性。因此,我们在此证明,核EGFR是DNA修复和顺铂治疗抗性所必需的。

相似文献

1
Nuclear EGFR is required for cisplatin resistance and DNA repair.细胞核表皮生长因子受体(EGFR)是顺铂耐药性和DNA修复所必需的。
Am J Transl Res. 2009 Mar 8;1(3):249-58.
2
EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.EGFR 核转位调节顺铂和电离辐射治疗后的 DNA 修复。
Cancer Res. 2011 Feb 1;71(3):1103-14. doi: 10.1158/0008-5472.CAN-10-2384. Epub 2011 Jan 25.
3
Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage.融合趾同源物的沉默通过抑制表皮生长因子受体介导的DNA损伤修复增强宫颈癌细胞对顺铂的敏感性。
Cancer Chemother Pharmacol. 2016 Oct;78(4):753-62. doi: 10.1007/s00280-016-3110-y. Epub 2016 Aug 17.
4
Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment.吉非替尼治疗后表皮生长因子受体与DNA依赖性蛋白激酶途径的相互作用。
Mol Cancer Ther. 2006 Feb;5(2):209-18. doi: 10.1158/1535-7163.MCT-05-0239.
5
Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654.电离辐射诱导的核 EGFR 转位受残基 Thr654 磷酸化调节。
FEBS Lett. 2010 Sep 24;584(18):3878-84. doi: 10.1016/j.febslet.2010.08.005. Epub 2010 Aug 7.
6
Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair.尼妥珠单抗通过阻断表皮生长因子受体内核转位并抑制辐射诱导的DNA损伤修复,增强非小细胞肺癌H292细胞的体外辐射敏感性。
Onco Targets Ther. 2015 Apr 13;8:809-18. doi: 10.2147/OTT.S77283. eCollection 2015.
7
Characterization of a novel tripartite nuclear localization sequence in the EGFR family.表皮生长因子受体(EGFR)家族中一种新型三方核定位序列的特征分析
J Biol Chem. 2007 Apr 6;282(14):10432-40. doi: 10.1074/jbc.M610014200. Epub 2007 Feb 5.
8
Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation.蛋白激酶Cε的激活通过表皮生长因子受体内核积累刺激DNA修复。
Radiother Oncol. 2008 Mar;86(3):383-90. doi: 10.1016/j.radonc.2007.10.041. Epub 2007 Nov 26.
9
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.达沙替尼是一种多激酶抑制剂,通过干扰表皮生长因子受体的核定位和阻断 DNA 修复途径来增加辐射敏感性。
Radiother Oncol. 2012 Nov;105(2):241-9. doi: 10.1016/j.radonc.2012.08.010. Epub 2012 Sep 23.
10
Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access.核表皮生长因子受体通过调节染色质可及性来调节细胞放射敏感性。
Radiother Oncol. 2011 Jun;99(3):317-22. doi: 10.1016/j.radonc.2011.06.001. Epub 2011 Jun 23.

引用本文的文献

1
Challenges and resistance mechanisms to EGFR targeted therapies in head and neck cancers and breast cancer: Insights into RTK dependent and independent mechanisms.头颈部癌和乳腺癌中EGFR靶向治疗的挑战与耐药机制:对RTK依赖性和非依赖性机制的见解
Oncotarget. 2025 Jun 25;16:508-530. doi: 10.18632/oncotarget.28747.
2
Female breast cancer classification using immunohistochemistry biomarkers staining in Botswana.在博茨瓦纳使用免疫组织化学生物标志物染色进行女性乳腺癌分类
BMC Cancer. 2025 May 19;25(1):893. doi: 10.1186/s12885-025-14251-4.
3
A new fluorescent oxaliplatin(iv) complex with EGFR-inhibiting properties for the treatment of drug-resistant cancer cells.一种具有表皮生长因子受体(EGFR)抑制特性的新型荧光奥沙利铂(IV)配合物,用于治疗耐药癌细胞。
Inorg Chem Front. 2025 Jan 9;12(4):1538-1552. doi: 10.1039/d4qi03025g. eCollection 2025 Feb 11.
4
From Bench to Bedside: A Team's Approach to Multidisciplinary Strategies to Combat Therapeutic Resistance in Head and Neck Squamous Cell Carcinoma.从实验室到临床:一个团队对抗头颈部鳞状细胞癌治疗耐药性的多学科策略方法
J Clin Med. 2024 Oct 10;13(20):6036. doi: 10.3390/jcm13206036.
5
Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas.克服头颈部鳞状细胞癌标准治疗的抵抗。
Cells. 2024 Jun 11;13(12):1018. doi: 10.3390/cells13121018.
6
Gene alterations in the nuclear transport receptor superfamily: A study of head and neck cancer.核转运受体超家族中的基因改变:头颈部癌症的研究。
PLoS One. 2024 May 31;19(5):e0300446. doi: 10.1371/journal.pone.0300446. eCollection 2024.
7
The efficacy and safety of EGFR-TKI in recurrent/metastatic nasopharyngeal carcinoma patients: A systematic review and meta-analysis.表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)在复发/转移性鼻咽癌患者中的疗效与安全性:一项系统评价和荟萃分析。
Laryngoscope Investig Otolaryngol. 2024 May 27;9(3):e1279. doi: 10.1002/lio2.1279. eCollection 2024 Jun.
8
YES1 as a potential target to overcome drug resistance in EGFR-deregulated non-small cell lung cancer.YES1 作为克服 EGFR 失调非小细胞肺癌耐药性的潜在靶点。
Arch Toxicol. 2024 May;98(5):1437-1455. doi: 10.1007/s00204-024-03693-7. Epub 2024 Mar 5.
9
Role of YES1 signaling in tumor therapy resistance.YES1信号通路在肿瘤治疗耐药中的作用。
Cancer Innov. 2023 Mar 3;2(3):210-218. doi: 10.1002/cai2.51. eCollection 2023 Jun.
10
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.表皮生长因子受体的核输出信号突变增强癌细胞的恶性表型。
Am J Cancer Res. 2023 Apr 15;13(4):1209-1239. eCollection 2023.

本文引用的文献

1
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer.表皮生长因子受体的核表达对卵巢癌患者具有新的预后价值。
Mol Carcinog. 2009 Jul;48(7):610-7. doi: 10.1002/mc.20504.
2
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia.DNA依赖蛋白激酶是B细胞慢性淋巴细胞白血病的一个治疗靶点及预后不良的指标。
Clin Cancer Res. 2008 Jun 15;14(12):3984-92. doi: 10.1158/1078-0432.CCR-07-5158.
3
Histone H2AX phosphorylation as a molecular pharmacological marker for DNA interstrand crosslink cancer chemotherapy.组蛋白H2AX磷酸化作为DNA链间交联癌症化疗的分子药理学标志物。
Biochem Pharmacol. 2008 Jul 1;76(1):19-27. doi: 10.1016/j.bcp.2008.03.025. Epub 2008 Apr 16.
4
The radioprotector Bowman-Birk proteinase inhibitor stimulates DNA repair via epidermal growth factor receptor phosphorylation and nuclear transport.放射防护剂鲍曼-伯克蛋白酶抑制剂通过表皮生长因子受体磷酸化和核转运刺激DNA修复。
Radiother Oncol. 2008 Mar;86(3):375-82. doi: 10.1016/j.radonc.2008.01.007. Epub 2008 Jan 30.
5
Activation of protein kinase Cepsilon stimulates DNA-repair via epidermal growth factor receptor nuclear accumulation.蛋白激酶Cε的激活通过表皮生长因子受体内核积累刺激DNA修复。
Radiother Oncol. 2008 Mar;86(3):383-90. doi: 10.1016/j.radonc.2007.10.041. Epub 2007 Nov 26.
6
DNA-dependent protein kinase in nonhomologous end joining: a lock with multiple keys?非同源末端连接中的DNA依赖性蛋白激酶:一把有多个钥匙的锁?
J Cell Biol. 2007 Oct 22;179(2):183-6. doi: 10.1083/jcb.200705106. Epub 2007 Oct 15.
7
The radioprotector O-phospho-tyrosine stimulates DNA-repair via epidermal growth factor receptor- and DNA-dependent kinase phosphorylation.辐射防护剂O-磷酸酪氨酸通过表皮生长因子受体和DNA依赖性激酶磷酸化刺激DNA修复。
Radiother Oncol. 2007 Sep;84(3):328-34. doi: 10.1016/j.radonc.2007.07.006. Epub 2007 Aug 21.
8
Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma.表皮生长因子受体(EGFR)酪氨酸激酶结构域中的体细胞突变可消除非小细胞肺癌中EGFR介导的辐射防护作用。
Cancer Res. 2007 Jun 1;67(11):5267-74. doi: 10.1158/0008-5472.CAN-07-0242.
9
Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.磷酸化表皮生长因子受体的核表达与食管鳞状细胞癌患者的不良预后相关。
Pathobiology. 2007;74(1):15-21. doi: 10.1159/000101047.
10
Characterization of a novel tripartite nuclear localization sequence in the EGFR family.表皮生长因子受体(EGFR)家族中一种新型三方核定位序列的特征分析
J Biol Chem. 2007 Apr 6;282(14):10432-40. doi: 10.1074/jbc.M610014200. Epub 2007 Feb 5.